Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 4—April 2011

Secondary and Tertiary Transmission of Vaccinia Virus from US Military Service Member

Gregory E. YoungComments to Author , Christina M. Hidalgo, Ann Sullivan-Frohm, Cynthia Schulte, Stephen Davis, Cassandra Kelly-Cirino, Christina Egan, Kimberly Wilkins, Ginny L. Emerson, Kimberly Noyes, and Debra Blog
Author affiliations: Author affiliations: New York State Department of Health, Buffalo, New York, USA (G.E. Young, C.M. Hidalgo, A. Sullivan-Frohm); New York State Department of Health, Albany, New York, USA (C. Schulte, S. Davis, C. Kelly-Cirino, C. Egan, K. Noyes, D. Blog); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Wilkins, G.L. Emerson)

Main Article


Cases of laboratory-confirmed secondary and tertiary transmission of vaccinia virus from US military service member, New York, USA, 2010*

No.† Transmission
type Age, y/sex Exposure
Underlying risk factors VIG Duration of lesions, wk
Date Source Type Onset Location of lesions
1 Secondary 26/M Feb 27 Military vaccinee Wrestling Mar 1 Face, neck, chest None No ≈3
2 Secondary 24/M Feb 27 Military vaccinee Wrestling ≈Mar 1 Face, neck, chin, eye None No‡ ≈3
3 Tertiary 25/M Mar 5 Case-patient 1 Wrestling Mar 7 Chest, trunk, arm Mild eczema No ≈7
4 Tertiary 29/F After March Case-patient 1 Household Mar 9 Face, mandible, nostril None Yes ≈3

*VIG, varicella immune globulin.
†Case-patient no.
‡Use of VIG not indicated; treated with trifluridine ophthalmic solution (3).

Main Article

  1. Casey  C, Vellozzi  C, Mootrey  GT, Chapman  LE, McCauley  M, Roper  MH, Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep. 2006;55(RR-1):116.PubMedGoogle Scholar
  2. Rotz  LD, Dotson  DA, Damon  IK, Becher  JA; Advisory Committee on Immunization Practices. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep. 2001;50(RR-10):125.PubMedGoogle Scholar
  3. Vaccine Healthcare Centers Network. Contact transmission fact sheet [cited 2010 Nov 30].
  4. Cono  J, Casey  CG, Bell  DM; Centers for Disease Control and Prevention. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep. 2003;52(No.RR-4):128.PubMedGoogle Scholar
  5. Centers for Disease Control and Prevention. Medical management of smallpox (vaccinia) vaccine adverse reactions: vaccinia immune globulin and cidofovir [cited 2010 Nov 29].
  6. Ropp  SL, Jin  Q, Knight  JC, Massung  RF, Esposito  JJ. PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J Clin Microbiol. 1995;33:206976.PubMedGoogle Scholar
  7. Wharton  M, Strikas  RA, Harpaz  R, Rotz  LD, Schwartz  B, Casey  CG, Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003;52:116.PubMedGoogle Scholar
  8. Centers for Disease Control and Prevention. CDC interim guidance for revaccination of eligible persons who participated in the US civilian smallpox preparedness and response program. October 2008 [cited 2010 Nov 29].
  9. Strikas  RA, Neff  LJ, Rotz  L, Cono  J, Knutson  D, Henderson  J, US Civilian Smallpox Preparedness and Response Program, 2003. Clin Infect Dis. 2008;46:S15767. DOIPubMedGoogle Scholar

Main Article

Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.